Brooks Laboratories Ltd (BROO)

Currency in INR
64.15
-0.95(-1.46%)
Closed·
BROO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
64.0065.95
52 wk Range
36.30163.90
Key Statistics
Bid/Ask
65.00 / 65.45
Prev. Close
65.1
Open
65.15
Day's Range
64-65.95
52 wk Range
36.3-163.9
Volume
24.89K
Average Volume (3m)
29.12K
1-Year Change
-53.7157%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BROO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-0,61 / --
Revenue / Forecast
229,61M / --
EPS Revisions
Last 90 days

BROO Income Statement

Compare BROO to Peers and Sector

Metrics to compare
BROO
Peers
Sector
Relationship
P/E Ratio
14.5x72.1x−0.4x
PEG Ratio
0.031.120.00
Price/Book
1.6x2.9x2.6x
Price / LTM Sales
2.3x4.4x3.1x
Upside (Analyst Target)
-10.2%49.0%
Fair Value Upside
Unlock−5.9%7.1%Unlock

Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections. It is also involved in loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries; and trading in pharmaceutical products, ingredients, and intermediaries. In addition, the company offers oncology products and hormonal injections; and formulations for therapeutic areas comprising antibiotic, pain management, controlled drugs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan, Nigeria, Lebanon, Mauritius, Sudan, Madagascar, the Democratic Republic of Congo, Angola, Mozambique, Latin America, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

Employees
347
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2,92M9,90%189,84M
Other Institutional Investors
341,00K1,16%22,20M
Public Companies & Retail Investors
26,20M88,94%1,71B
Total
29,46M100,00%1,92B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
quant Money Managers Ltd.9,90%2 916 111189 839
Quant Money Managers Limited - Quant Business Cycle Fund9,90%2 916 111189 839

FAQ

What Is the Brooks Laboratories Ltd (BROO) Stock Price Today?

The Brooks Laboratories Ltd stock price today is 64,15 INR.

What Stock Exchange Does Brooks Laboratories Ltd Trade On?

Brooks Laboratories Ltd is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Brooks Laboratories Ltd?

The stock symbol for Brooks Laboratories Ltd is "BROO."

What Is the Brooks Laboratories Ltd Market Cap?

As of today, Brooks Laboratories Ltd market cap is 1,89B INR.

What Is Brooks Laboratories Ltd's Earnings Per Share (TTM)?

The Brooks Laboratories Ltd EPS (TTM) is 4,49.

From a Technical Analysis Perspective, Is BROO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Brooks Laboratories Ltd Stock Split?

Brooks Laboratories Ltd has split 1 times.

How Many Employees Does Brooks Laboratories Ltd Have?

Brooks Laboratories Ltd has 347 employees.

What is the current trading status of Brooks Laboratories Ltd (BROO)?

As of Sep 03, 2026, Brooks Laboratories Ltd (BROO) is trading at a price of 64,15 INR, with a previous close of 65,10 INR. The stock has fluctuated within a day range of 64,00 INR to 65,95 INR, while its 52-week range spans from 36,30 INR to 163,90 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.